Current Efficacy and Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
² Louisiana State University Health Shreveport School of Medicine, Shreveport, Louisiana, USA.
³ Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, Austin, Texas, USA.
⁴ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA; Department of Surgery, Overton Brooks Veterans Administration Medical Center, Shreveport, Louisiana, USA.
⁵ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA. Electronic address: alok.khandelwal@lsuhs.edu.

Srivatsa Surya Vasudevan et al. J Invest Dermatol. 2025 Oct.

. 2025 Oct;145(10):2623-2626.e5.

doi: 10.1016/j.jid.2025.03.016. Epub 2025 Apr 1.

¹ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
² Louisiana State University Health Shreveport School of Medicine, Shreveport, Louisiana, USA.
³ Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, Austin, Texas, USA.
⁴ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA; Department of Surgery, Overton Brooks Veterans Administration Medical Center, Shreveport, Louisiana, USA.
⁵ Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA. Electronic address: alok.khandelwal@lsuhs.edu.

No abstract available

Keywords: Anti–PD-1; Cell carcinoma; Cutaneous squamous; Head and neck skin cancer; PD-1.

LinkOut - more resources